Skip to main content

PETS at ICPE 2021

PETS Faculty, Staff, and Trainees attended and presented their research at the 37th International Conference for Pharmacoepidemiology. The conference took place virtually throughout the month of August, with the core … Read More

Jesse Berlin, ScD

Dr. Berlin received his doctorate in biostatistics from the Harvard School of Public Health in 1988. After spending 15 years as a faculty member at the University of Pennsylvania, in … Read More

Stephen Crystal, PhD

About Dr. Crystal is Board of Governors Professor of Health  Services Research at Rutgers University, where he directs the Center for Health Services Research. He is recognized nationally for his rigorous … Read More

Sandra Lopez Leon, MD, PhD

About Sandra Lopez-Leon is a genetic pharmacoepidemiologist focused on studying the safety of new neuropsychiatric medications at all stages of drug development. She graduated from the Erasmus University Medical Center … Read More

Christopher G. Rowan, PhD

About Christopher G. Rowan PhD (Chris) is the Founder and Principal Investigator of Veritas Research Foundation (501(c)(3)) and Adjunct Associate Professor at Rutgers University Center for Pharmacoepidemiology and Treatment Sciences … Read More

Jason Roy, PhD

About Jason Roy is a Professor of Biostatistics and Chair of the Department of Biostatistics and Epidemiology. He is director of Rutgers University Biostatics and Epidemiology Services (RUBIES) and co-director … Read More

Melanie Rua

About Melanie Rua, PharmD, MPH is a Research Associate at the Center for Pharmacoepidemiology and Treatment Science. She is a licensed pharmacist who has worked in both a hospital and … Read More

Matthew Beier

About Matt Beier is a medical student at Rutgers, Robert Wood Johnson Medical School working under the guidance of Dr. Daniel Horton.  He previously earned a B.S. in Chemical Engineering … Read More

Daniel Dudman

About Daniel Dudman (Butler University, 2019) is a post-doctoral fellow in Quantitative Safety & Epidemiology at the Rutgers Institute for Pharmaceutical Industry Fellowships and Novartis. Daniel has a background in … Read More